关注
Kathryne Marks
Kathryne Marks
Brigham and Women's Hospital
在 bwh.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Fatty acid synthase regulates the pathogenicity of Th17 cells
KE Young, S Flaherty, KM Woodman, N Sharma‐Walia, JM Reynolds
Journal of leukocyte biology 102 (5), 1229-1235, 2017
702017
T peripheral helper cells in autoimmune diseases
KE Marks, DA Rao
Immunological Reviews 307 (1), 191-202, 2022
582022
Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes
F Zhang, AH Jonsson, A Nathan, N Millard, M Curtis, Q Xiao, ...
Nature, 1-9, 2023
462023
Toll-like Receptor 2 in Autoimmune Inflammation
KE Marks, K Cho, C Stickling, JM Reynolds
Immune Network 21 (3), 2021
282021
Clonally expanded CD38hi cytotoxic CD8 T cells define the T cell infiltrate in checkpoint inhibitor–associated arthritis
R Wang, A Singaraju, KE Marks, L Shakib, G Dunlap, I Adejoorin, ...
Science immunology 8 (85), eadd1591, 2023
222023
Toll-like receptor 2 induces pathogenicity in Th17 cells and reveals a role for IPCEF in regulating Th17 cell migration
KE Marks, S Flaherty, KM Patterson, M Stratton, GJ Martinez, ...
Cell reports 35 (13), 2021
142021
Rheumatoid arthritis disease activity assessed by patient-reported outcomes and flow cytometry before and after an additional dose of COVID-19 vaccine
SK Tedeschi, J Stratton, JE Ellrodt, MG Whelan, K Hayashi, K Yoshida, ...
Annals of the Rheumatic Diseases 81 (7), 1045-1048, 2022
132022
Importance of Shared Treatment Goal Discussions in Rheumatoid Arthritis—A Cross‐Sectional Survey: Patients Report Providers Seldom Discuss Treatment Goals and Outcomes Improve …
KD O’Neill, KE Marks, PS Sinicrope, CS Crowson, D Symons, ...
ACR Open Rheumatology 3 (12), 870-878, 2021
52021
Associations between rheumatoid arthritis clinical factors with synovial cell types and states
D Weisenfeld, F Zhang, L Donlin, AH Jonsson, W Apruzzese, D Campbell, ...
Arthritis & Rheumatology, 2023
42023
Humoral and cellular immune responses in persons with rheumatoid arthritis after a third dose of mRNA COVID-19 vaccine
SK Tedeschi, DH Solomon, Y Chen, J Ellrodt, MG Whelan, J Stratton, ...
Seminars in Arthritis and Rheumatism 59, 152177, 2023
42023
High-dimensional immunophenotyping reveals immune cell aberrations in patients with undiagnosed inflammatory and autoimmune diseases
AA Mueller, T Sasaki, JW Keegan, JP Nguyen, A Griffith, AM Horisberger, ...
The Journal of Clinical Investigation, 2023
22023
RA Presents in Disease Patterns Impacting Treatment Response
K Marks, D Symons, C Crowson, P Sinicrope, K O'Neill
ARTHRITIS & RHEUMATOLOGY 71, 2019
22019
Toll-like receptor 2 induces pathogenicity in Th17 cells and reveals a role for interactor protein for cytohesin exchange factors 1 (IPCEF) in regulating Th17 cell migration
K Marks, S Flaherty, M Stratton, GJ Martinez, JM Reynolds
Available at SSRN 3701221, 2021
12021
Relationships Between Disease Patterns in RA and Rheumatology Treatment
K O'Neill, K Marks, J Davis, C Crowson
ARTHRITIS & RHEUMATOLOGY 72, 2020
12020
OP0015 CD38HI CYTOTOXIC CD8 T CELLS ARE EXPANDED FOLLOWING CHECKPOINT BLOCKADE AND CHARACTERIZE THE T CELL INFILTRATE IN CHECKPOINT INHIBITOR-ASSOCIATED ARTHRITIS
A Singaraju, KE Marks, R Wang, L Shakib, G Dunlap, ...
Annals of the Rheumatic Diseases 82 (Suppl 1), 10-11, 2023
2023
Relationship Between Humoral and Cellular Immune Responses in Persons with Rheumatoid Arthritis Following a Third Dose of COVID-19 Vaccine
S Tedeschi, D Solomon, Y Chen, J Ellrodt, MG Whelan, J Stratton, ...
ARTHRITIS & RHEUMATOLOGY 74, 1568-1570, 2022
2022
Themes in Patients' Discordance with Provider's Rheumatoid Arthritis Treatment Goals Relate to Patient Age, Gender, and Ethnicity
K O'Neill, P Sinicrope, C Crowson, K Marks, R Giblon, E Myasoedova, ...
ARTHRITIS & RHEUMATOLOGY 74, 399-401, 2022
2022
Distinct Effects of JAK Inhibitor and TNF Inhibitors on Circulating B Cell Phenotypes in Rheumatoid Arthritis Patients
M Elahee, K Marks, I Adejoorin, L Chen, D Todd, J Coblyn, E Massarotti, ...
ARTHRITIS & RHEUMATOLOGY 74, 1246-1248, 2022
2022
Rheumatoid Arthritis Patient Discordance with Provider Treatment Goals Is Associated with Poorer RA Outcomes
K O'Neill, P Sinicrope, C Crowson, K Marks, R Giblon, E Myasoedova, ...
ARTHRITIS & RHEUMATOLOGY 74, 4464-4467, 2022
2022
POS0402 CLONALLY EXPANDED CD38hi CYTOTOXIC CD8 T CELLS DEFINE THE T CELL INFILTRATE IN CHECKPOINT INHIBITOR-ASSOCIATED ARTHRITIS
R Wang, A Singaraju, KE Marks, L Shakib, G Dunlap, ...
Annals of the Rheumatic Diseases 81 (Suppl 1), 457-457, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20